Differential expression of ABCB1, ABCG2, and KLF4 as putative indicators for paclitaxel resistance in human epithelial type 2 cells
- 28 January 2021
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 48 (2) , 1393-1400
Abstract
Laryngeal squamous cell carcinoma (LSCC) is the second most common malignancy of the head and neck region in the USA with a declining 5-year survival rate. Paclitaxel resistance of tumors including LSCC still stands as a vital cause for poor clinical outcome in patients. In the current study, our aim was to explore the expressions of ATP-binding cassette transporters and stemness associated genes in human epithelial type 2 (Hep-2) cells with paclitaxel resistance. Resistant cells were developed via treatment with increasing doses of paclitaxel to acquire four sub-lines resistant to one-, two-, four-, and eightfold concentrations of paclitaxel (1×, 2×, 4×, 8×). Then, we profiled the expressions of ten selected ABC transporters (ABCA5, ABCB1, ABCB6, ABCC1, ABCC2, ABCC3, ABCC5, ABCC10, ABCF2, and ABCG2) and four stem cell markers (SOX2, OCT4, KLF, and CXCR4) using quantitative real time polymerase chain reaction in paclitaxel resistant cells to look for a link between these markers and chemoresistance. We demonstrated that ABCB1 and ABCG2 expressions gradually elevated and reached a maximum level in Taxol 8× cells. Considering stem cell markers, KLF4 expression elevated significantly, as soon as parental cells acquired resistance to the lowest dose of paclitaxel and its expression elevated stepwise. Expression levels of other tested ATP-binding cassette transporters and stem cell markers also elevated, although at different steps of paclitaxel resistance acquisition. Our findings suggest that higher expressions of ABCB1, ABCG2, and KLF4 might be considered as putative indicators for paclitaxel resistance in LSCC patients.Keywords
This publication has 29 references indexed in Scilit:
- Mechanisms of chemoresistance in cancer stem cellsClinical and Translational Medicine, 2013
- Identification of CBX3 and ABCA5 as Putative Biomarkers for Tumor Stem Cells in OsteosarcomaPLOS ONE, 2012
- Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanomaLaboratory Investigation, 2012
- Expression of the 49 human ATP binding cassette (ABC) genes in pluripotent embryonic stem cells and in early- and late-stage multipotent mesenchymal stem cellsCell Cycle, 2012
- Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomasOral Oncology, 2011
- ABC transporters in cancer: more than just drug efflux pumpsNature Reviews Cancer, 2010
- Role of drug transporters and drug accumulation in the temporal acquisition of drug resistanceBMC Cancer, 2008
- The characteristics of Hep‐2 cell with multiple drug resistance induced by TaxolOtolaryngology–Head and Neck Surgery, 2007
- Mechanisms of Taxol resistance related to microtubulesOncogene, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001